Artwork

Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Replay: Exploring the Potential of Mahana’s Innovative Digital Treatments for IBS

38:47
 
Share
 

Manage episode 375574455 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Have you heard? On August 22, Mahana Therapeutics announced a distribution and marketing partnership with Bayer’s consumer health division. This partnership unites Mahana’s proficiency in digital therapeutic advancement with Bayer’s commitment to empowering individuals through cutting-edge digital solutions, all aimed at enabling greater personal health control. The full press release is linked below.

In light of this, we’re bringing you this replay episode with Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana.

In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app.

In this episode, we cover:

  • The founding story and funding journey of Mahana
  • Complexities of the end to end patient experience
  • The freemium model and how that translates into a PDT
  • Evidence generation and FDA clearance process
  • Scaling plans for PDTs

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health | Orion Pharma

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 375574455 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Have you heard? On August 22, Mahana Therapeutics announced a distribution and marketing partnership with Bayer’s consumer health division. This partnership unites Mahana’s proficiency in digital therapeutic advancement with Bayer’s commitment to empowering individuals through cutting-edge digital solutions, all aimed at enabling greater personal health control. The full press release is linked below.

In light of this, we’re bringing you this replay episode with Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana.

In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app.

In this episode, we cover:

  • The founding story and funding journey of Mahana
  • Complexities of the end to end patient experience
  • The freemium model and how that translates into a PDT
  • Evidence generation and FDA clearance process
  • Scaling plans for PDTs

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health | Orion Pharma

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide